Castle Biosciences CSTL Property, plant and equipment, net
Property, plant and equipment, net at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's property, plant and equipment, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's property, plant and equipment, net?
- Castle Biosciences (CSTL) reported property, plant and equipment, net of $100.93M in Q1 2026.
- How has Castle Biosciences's property, plant and equipment, net changed year-over-year?
- Castle Biosciences's property, plant and equipment, net increased by 82.1% year-over-year, from $55.42M to $100.93M.
- What is the long-term trend for Castle Biosciences's property, plant and equipment, net?
- Over 5 years (2020 to 2025), Castle Biosciences's property, plant and equipment, net has grown at a 68.8% compound annual growth rate (CAGR), from $7.1M to $97.44M.
- What does property, plant and equipment, net mean?
- This represents the net book value of long-term tangible assets used in the production, distribution, and administrative functions of the business. It includes manufacturing facilities, machinery, and equipment after accounting for accumulated depreciation. This metric is central to assessing the capital intensity of the company's operations.